logo

GDRX

Goodrx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 2
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About GDRX

Goodrx Holdings, Inc.

A provider of healthcare technology and consumer-focused digital healthcare platform in the US

Healthcare Technology
--
09/23/2020
NASDAQ Stock Exchange
738
12-31
Common stock
2701 Olympic Boulevard, Santa Monica, CA 90404
--
Goodrx Holdings, Inc., was founded in Delaware. The company aims to address the challenges consumers face in understanding, accessing and delivering healthcare. The company started with a price comparison tool for prescriptions, offering consumers lower drug prices for free. Today, the company believes that its expanded platform can improve the health and financial well-being of American families through easy access to price transparency and affordability solutions for generic and branded drugs, affordable and convenient medical provider consultation through telemedicine and other medical services and information.

Earnings Call

Company Financials

EPS

GDRX has released its 2025 Q3 earnings. EPS was reported at 0.08, versus the expected 0.09, missing expectations. The chart below visualizes how GDRX has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

GDRX has released its 2025 Q3 earnings report, with revenue of 196.03M, reflecting a YoY change of 0.40%, and net profit of 1.12M, showing a YoY change of -71.78%. The Sankey diagram below clearly presents GDRX's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime